When, which and how to switch: Navigating JAK inhibitors in myelofibrosis.
O'Sullivan J., Omerdeen I., Psaila B.
Navigating choice of JAK inhibitor (JAKi) therapy for patients with myelofibrosis who are JAKi-naïve and for those who have previously been treated with a JAKi.